Top Markets
Coin of the day
Shandong Jincheng Pharmaceutical Group Co., Ltd Shandong Jincheng Pharmaceutical Group Co., Ltd

Shandong Jincheng Pharmaceutical Group Co., Ltd

300233
Rang in Aktien #11178
Shandong Jincheng Pharmaceutical Group Co., Ltd., together with its affiliated... Shandong Jincheng Pharmaceutical Group Co., Ltd., together with its affiliated companies, focuses on the global research, development, manufacturing, and distribution of Cephalosporin intermediates. The Group's extensive product line includes active pharmaceutical ingredients (APIs), biopharmaceutical products, various medical intermediates, specialty fine chemicals, and final dosage form medications. Additionally, it diversifies its operations by offering animal nutrition and healthcare products, as well as providing contract manufacturing (CMO) and contract development and manufacturing (CDMO) services. Established in 2004, the company is headquartered in Zibo, China.
Aktienkurs
$1.93
Zuletzt synchronisiert: 2026-08-28
Marktkapitalisierung
$732.21M
Veränderung (1 Tag)
-1.33%
Veränderung (1 Jahr)
-28.12%
Land
CN
Handel Shandong Jincheng Pharmaceutical Group Co., Ltd (300233)
Dividendenrendite-Verlauf für Shandong Jincheng Pharmaceutical Group Co., Ltd (300233)
Dividendenrendite (TTM) von Shandong Jincheng Pharmaceutical Group Co., Ltd (Aktienkürzel: 300233) zum 2026: 0
Durchschnittliche Dividendenrendite der letzten 5 Jahre: 0.00%
Dividendenrendite-Verlauf für Shandong Jincheng Pharmaceutical Group Co., Ltd (300233) von 2026 bis 2026
Dividendenrendite am Ende jedes Jahres (TTM)
Jahr Dividendenrendite ändert
Nicht genügend Daten für die angegebenen Daten.
Dividendenrenditen (TTM) für ähnliche Unternehmen oder Wettbewerber